Indian Pharma market sees growth of 12.1 percent in August 2022: AIOCD-AWACS Report

Published On 2022-09-10 11:18 GMT   |   Update On 2024-01-23 11:39 GMT
Advertisement
The Indian Pharmaceutical Market (IPM) saw significant growth of 12.1 percent in value and 4.8 percent in volume, in the month of August, 2022, says market research firm All India Organization of Chemists and Druggists (AIOCD-AWACS).
"A robust 12% growth of the IPM seems to be supported by a good volume driven growth for majority of the therapy areas," the AWACS report said. It also claimed that COVID influence had reduced drastically by July 21 last year and most of the therapies had started following the normal seasonal trends. For the month of August 22, price increase led growth seems to be slightly higher than the volume growth.
Advertisement
For more details, check out the link given below:
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News